{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:00:13Z","timestamp":1784782813911,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T00:00:00Z","timestamp":1499212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00774-017-0831-x","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T11:22:42Z","timestamp":1499253762000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Therapeutic effect of icariin combined with stem cells on postmenopausal osteoporosis in rats"],"prefix":"10.1007","volume":"36","author":[{"given":"Dao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiling","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,5]]},"reference":[{"key":"831_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0950-3579(05)80075-5","volume":"7","author":"R Lindsay","year":"1993","unstructured":"Lindsay R (1993) Pathogenesis of postmenopausal osteoporosis. Baillieres Clin Rheumatol 7:499\u2013513","journal-title":"Baillieres Clin Rheumatol"},{"key":"831_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S1550-8579(04)80013-5","volume":"1","author":"BJ Edwards","year":"2004","unstructured":"Edwards BJ, Brooks ER, Langman CB (2004) Osteoporosis screening of postmenopausal women in the primary care setting: a case-based approach. Gend Med 1:70\u201385","journal-title":"Gend Med"},{"key":"831_CR3","first-page":"107","volume":"4","author":"Harinarayan CV Meeta","year":"2013","unstructured":"Meeta Harinarayan CV, Marwah R, Sahay R, Kalra S, Babhulkar S (2013) Clinical practice guidelines on postmenopausal osteoporosis: an executive summary and recommendations. J Midlife Health 4:107\u2013126","journal-title":"J Midlife Health"},{"key":"831_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF01622200","volume":"4","author":"JA Kanis","year":"1994","unstructured":"Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4:368\u2013381","journal-title":"Osteoporos Int"},{"key":"831_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/2225-4110.110407","volume":"3","author":"PC Leung","year":"2013","unstructured":"Leung PC, Siu WS (2013) Herbal treatment for osteoporosis: a current review. J Tradit Complement Med 3:82\u201387","journal-title":"J Tradit Complement Med"},{"key":"831_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bone.2015.06.008","volume":"79","author":"PS Hinton","year":"2015","unstructured":"Hinton PS, Nigh P, Thyfault J (2015) Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: a 12-month randomized, clinical trial. Bone 79:203\u2013212","journal-title":"Bone"},{"key":"831_CR7","first-page":"155","volume":"12","author":"RK Evans","year":"2012","unstructured":"Evans RK, Negus CH, Centi AJ, Spiering BA, Kraemer WJ, Nindl BC (2012) Peripheral QCT sector analysis reveals early exercise induced increases in tibial bone mineral density. J Musculoskelet Neuronal Interact 12:155\u2013164","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"831_CR8","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1056\/NEJMcp1210380","volume":"369","author":"DC Bauer","year":"2013","unstructured":"Bauer DC (2013) Calcium supplements and fracture prevention. N Engl J Med 369:1537\u20131543","journal-title":"N Engl J Med"},{"key":"831_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJMoa055218","volume":"354","author":"RD Jackson","year":"2006","unstructured":"Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669\u2013683","journal-title":"N Engl J Med"},{"key":"831_CR10","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1210\/jc.2011-3060","volume":"97","author":"MH Murad","year":"2012","unstructured":"Murad MH, Drake MT, Mullan RJ, Mauck KF, Stuart LM, Lane MA, Abu Elnour NO, Erwin PJ, Hazem A, Puhan MA, Li T, Montori VM (2012) Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta analysis. J Clin Endocrinol Metab 97:1871\u20131880","journal-title":"J Clin Endocrinol Metab"},{"key":"831_CR11","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","volume":"290","author":"JA Cauley","year":"2003","unstructured":"Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2019s Health Initiative randomized trial. JAMA 290:1729\u20131738","journal-title":"JAMA"},{"key":"831_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.7326\/M14-0317","volume":"161","author":"CJ Crandall","year":"2014","unstructured":"Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ, Motala A, Shekelle PG (2014) Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med 161:711\u2013723","journal-title":"Ann Intern Med"},{"key":"831_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"831_CR14","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"831_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF03026324","volume":"23","author":"L Qin","year":"2005","unstructured":"Qin L, Zhang G, Hung WY, Shi Y, Leung K, Yeung HY, Leung P (2005) Phytoestrogen rich herb formula \u201cXLGB\u201d prevent OVX-induced deterioration of musculoskeletal tissues. J Bone Miner Metab 23:55\u201361","journal-title":"J Bone Miner Metab"},{"key":"831_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1248\/bpb.29.291","volume":"29","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Lai WP, Wong MS (2006) Effects of Fracutus Ligustri Lucidi extract on bone turn over and calcium balance in ovariectomized rats. Biot Pharm Bull 29:291\u2013296","journal-title":"Biot Pharm Bull"},{"key":"831_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/GME.0000000000000201","volume":"21","author":"GW Li","year":"2014","unstructured":"Li GW, Xu Z, Chang SX, Nian H, Wang XY, Qin LD (2014) Icariin prevents ovariectomy-induced bone loss and lowers marrow adipogenesis. Menopause 21:1007\u20131016","journal-title":"Menopause"},{"key":"831_CR18","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3736\/jcim20121111","volume":"10","author":"XY Mao","year":"2012","unstructured":"Mao XY, Bian Q, Shen ZY (2012) Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1\/2 by icariin via MAPK signaling pathway in vitro. Zhong Xi Yi Jie He Xue Bao 10:1272\u20131278","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"831_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.18553\/jmcp.2012.18.s4-b.1","volume":"18","author":"S Levis","year":"2012","unstructured":"Levis S, Theodore GJ (2012) Summary of AHRQ\u2019s comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. Manag Care Pharm 18:S1\u201315","journal-title":"Manag Care Pharm"},{"key":"831_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"Black DM (2016) Postmenopausal osteoporosis. N Engl J Med 374:254\u2013262","journal-title":"N Engl J Med"},{"key":"831_CR21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3760\/cma.j.issn.0366-6999.20122380","volume":"126","author":"S Kapoor","year":"2013","unstructured":"Kapoor S (2013) Icariin and its emerging role in the treatment osteoporosis. Chin Med J (Engl) 126:400","journal-title":"Chin Med J (Engl)"},{"key":"831_CR22","first-page":"1784","volume":"125","author":"M Liu","year":"2012","unstructured":"Liu M, Zhong C, He RX, Chen LF (2012) Icariin associated with exercise therapy is an effective treatment for postmenopausal osteoporosis. Chin Med J (Engl) 125:1784\u20131789","journal-title":"Chin Med J (Engl)"},{"key":"831_CR23","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1359\/jbmr.070405","volume":"22","author":"G Zhang","year":"2007","unstructured":"Zhang G, Qin L, Shi Y (2007) Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double- blind and placebo-controlled trial. J Bone Miner Res 22:1072\u20131079","journal-title":"J Bone Miner Res"},{"key":"831_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/GME.0000000000000408","volume":"22","author":"AI Caplan","year":"2015","unstructured":"Caplan AI (2015) Adult mesenchymal stem cells and women\u2019s health. Menopause 22:131\u2013135","journal-title":"Menopause"},{"key":"831_CR25","doi-asserted-by":"publisher","first-page":"829650","DOI":"10.1155\/2012\/829650","volume":"2012","author":"EJ Kwak","year":"2012","unstructured":"Kwak EJ, Lee YS, Choi EM (2012) Effect of magnolol on the function of osteoblastic MC3T3-E1 cells. Mediat Inflamm 2012:829650","journal-title":"Mediat Inflamm"},{"key":"831_CR26","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.bone.2012.02.004","volume":"50","author":"R Eastell","year":"2012","unstructured":"Eastell R, Reid DM, Vukicevic S, Ensrud KE, LaCroix AZ, Thompson JR, Thompson DD, Cummings SR (2012) Effects of 3\u00a0years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis. Bone 50:1135\u20131140","journal-title":"Bone"},{"key":"831_CR27","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1476-5381.2009.00593.x","volume":"159","author":"SK Mok","year":"2010","unstructured":"Mok SK, Chen WF, Lai WP, Leung PC, Wang XL, Yao XS, Wong MS (2010) Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol 159:939\u2013949","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-017-0831-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-017-0831-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-017-0831-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T07:27:59Z","timestamp":1719300479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-017-0831-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s00774-017-0831-x","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,5]]},"assertion":[{"value":"11 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}